Chen et al. [32] emphasized that FOXO3 expression is related to shorter survival time and cancer progression in invasive ductal breast carcinoma, which was also observed in glioblastoma human samples [33]. This evidence concerns the gene FOXO3 and invasive ductal breast carcinoma.